Avidity Partners Management LP
- SEC CIK
- 0001791827
- 最新申報
- 2026/8/14
2023 年第 3 季持倉
持倉截至 2023/9/30，2023/11/14 申報。只含多頭部位，變化是跟 2023 年第 2 季比股數。
- 持股檔數
- 83
- 較 2023 年第 2 季 −10
- 總值
- $24.8 億
- 較 2023 年第 2 季 −$3.80 億 (−13.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| BSXBoston Scientific Corp | Stock | 2,065,800 | $1.09 億 | 4.4% | +1,280,100+162.9% | 加碼 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 797,500 | $1.03 億 | 4.2% | +94,722+13.5% | 加碼 | 歷史 |
| BDXBecton Dickinson & Co | Stock | 286,800 | $7,415 萬 | 3.0% | −111,250−27.9% | 減碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 652,100 | $7,336 萬 | 3.0% | −13,216−2.0% | 減碼 | 歷史 |
| MCKMcKesson Corp | Stock | 166,300 | $7,232 萬 | 2.9% | +65,100+64.3% | 加碼 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 967,000 | $6,495 萬 | 2.6% | +168,100+21.0% | 加碼 | 歷史 |
| THCTenet Healthcare Corp | COM NEW | 963,800 | $6,350 萬 | 2.6% | −26,700−2.7% | 減碼 | 歷史 |
| CICigna Group | Stock | 207,700 | $5,942 萬 | 2.4% | +207,700 | 新進 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,144,971 | $5,787 萬 | 2.3% | −840,729−28.2% | 減碼 | 歷史 |
| UNHUnitedHealth Group Inc | Stock | 112,200 | $5,657 萬 | 2.3% | +112,200 | 新進 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 450,000 | $5,455 萬 | 2.2% | +152,500+51.3% | 加碼 | 歷史 |
| HUMHumana Inc | Stock | 110,300 | $5,366 萬 | 2.2% | +110,300 | 新進 | 歷史 |
| ARVNArvinas, Inc. | COM | 2,614,960 | $5,136 萬 | 2.1% | −158,229−5.7% | 減碼 | 歷史 |
| ACHCAcadia Healthcare Company, Inc. | COM | 715,000 | $5,027 萬 | 2.0% | +165,000+30.0% | 加碼 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 286,700 | $4,848 萬 | 2.0% | −155,500−35.2% | 減碼 | 歷史 |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 58,000 | $4,773 萬 | 1.9% | +33,200+133.9% | 加碼 | 歷史 |
| ZTSZoetis Inc. | Stock | 262,100 | $4,560 萬 | 1.8% | +45,100+20.8% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 1,173,662 | $4,506 萬 | 1.8% | −911,338−43.7% | 減碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 777,172 | $4,430 萬 | 1.8% | +377,172+94.3% | 加碼 | 歷史 |
| DHRDanaher Corp | Stock | 176,600 | $4,381 萬 | 1.8% | +176,600 | 新進 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 2,100,000 | $4,213 萬 | 1.7% | −234,000−10.0% | 減碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 801,100 | $4,173 萬 | 1.7% | +801,100 | 新進 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,821,000 | $4,096 萬 | 1.6% | −51,000−1.8% | 減碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 75,000 | $4,028 萬 | 1.6% | −58,000−43.6% | 減碼 | 歷史 |
| NTRANatera, Inc. | COM | 899,000 | $3,978 萬 | 1.6% | +466,100+107.7% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 80,600 | $3,963 萬 | 1.6% | −103,700−56.3% | 減碼 | 歷史 |
| SGRYSurgery Partners, Inc. | Stock | 1,338,000 | $3,914 萬 | 1.6% | −217,000−14.0% | 減碼 | 歷史 |
| LNTHLantheus Holdings, Inc. | Stock | 558,400 | $3,880 萬 | 1.6% | +313,300+127.8% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 756,165 | $3,855 萬 | 1.6% | −118,835−13.6% | 減碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 751,600 | $3,775 萬 | 1.5% | +336,600+81.1% | 加碼 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 739,100 | $3,738 萬 | 1.5% | −285,900−27.9% | 減碼 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 1,142,850 | $3,611 萬 | 1.5% | +1,142,850 | 新進 | 歷史 |
| PRVAPrivia Health Group, Inc. | COM | 1,545,100 | $3,554 萬 | 1.4% | +465,294+43.1% | 加碼 | 歷史 |
| DXCMDexcom Inc | COM | 377,700 | $3,524 萬 | 1.4% | +377,700 | 新進 | 歷史 |
| BHVNBiohaven Ltd. | COM | 1,285,400 | $3,343 萬 | 1.3% | −39,600−3.0% | 減碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,587,429 | $3,253 萬 | 1.3% | +261,429+19.7% | 加碼 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 1,756,940 | $3,217 萬 | 1.3% | +855,540+94.9% | 加碼 | 歷史 |
| IMGNImmunoGen, Inc. | COM | 1,917,907 | $3,044 萬 | 1.2% | −79,893−4.0% | 減碼 | 歷史 |
| BIIBBiogen Inc. | COM | 115,400 | $2,966 萬 | 1.2% | −58,600−33.7% | 減碼 | 歷史 |
| CRBUCaribou Biosciences, Inc. | COM | 6,050,212 | $2,892 萬 | 1.2% | +3,291,612+119.3% | 加碼 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 1,063,897 | $2,859 萬 | 1.2% | +138,897+15.0% | 加碼 | 歷史 |
| HCAHCA Healthcare, Inc. | COM | 114,800 | $2,824 萬 | 1.1% | +114,800 | 新進 | 歷史 |
| NMRANeumora Therapeutics, Inc. | COM | 1,800,000 | $2,540 萬 | 1.0% | +1,800,000 | 新進 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 500,000 | $2,521 萬 | 1.0% | +462,200+1,222.8% | 加碼 | 歷史 |
| UHSUniversal Health Services Inc | CL B | 182,000 | $2,288 萬 | 0.9% | −188,100−50.8% | 減碼 | 歷史 |
| Curevac N VN2451R105 | COM | 3,116,100 | $2,128 萬 | 0.9% | −1,183,900−27.5% | 減碼 | – |
| AXSMAxsome Therapeutics, Inc. | COM | 296,800 | $2,074 萬 | 0.8% | −248,200−45.5% | 減碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 544,000 | $1,939 萬 | 0.8% | −356,700−39.6% | 減碼 | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 382,305 | $1,845 萬 | 0.7% | −152,695−28.5% | 減碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 657,200 | $1,819 萬 | 0.7% | −417,800−38.9% | 減碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 610,000 | $1,814 萬 | 0.7% | +610,000 | 新進 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 348,200 | $1,807 萬 | 0.7% | −226,800−39.4% | 減碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 1,503,302 | $1,756 萬 | 0.7% | −184,198−10.9% | 減碼 | 歷史 |
| ANTXAN2 Therapeutics, Inc. | COM | 1,089,400 | $1,752 萬 | 0.7% | +432,200+65.8% | 加碼 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,617,300 | $1,677 萬 | 0.7% | −332,400−17.0% | 減碼 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 1,217,554 | $1,664 萬 | 0.7% | +1,217,554 | 新進 | 歷史 |
| FUSNFusion Pharmaceuticals Inc. | COM | 5,781,850 | $1,503 萬 | 0.6% | +81,850+1.4% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 643,000 | $1,404 萬 | 0.6% | +141,800+28.3% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 830,300 | $1,353 萬 | 0.5% | −124,200−13.0% | 減碼 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 354,900 | $1,233 萬 | 0.5% | −337,600−48.8% | 減碼 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 379,100 | $1,199 萬 | 0.5% | −16,755−4.2% | 減碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 1,323,000 | $1,183 萬 | 0.5% | +1,323,000 | 新進 | 歷史 |
| SDGRSchrodinger, Inc. | COM | 399,000 | $1,128 萬 | 0.5% | +124,100+45.1% | 加碼 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 8,298,570 | $1,112 萬 | 0.4% | −71,530−0.9% | 減碼 | 歷史 |
| RYZBRayzeBio, Inc. | COM | 500,000 | $1,110 萬 | 0.4% | +500,000 | 新進 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 321,400 | $1,098 萬 | 0.4% | −159,900−33.2% | 減碼 | 歷史 |
| PACBPacific Biosciences of California, Inc. | COM | 1,034,294 | $863.6 萬 | 0.3% | −3,303,106−76.2% | 減碼 | 歷史 |
| ACIUAC Immune SA | SHS | 2,969,800 | $846.4 萬 | 0.3% | +66,522+2.3% | 加碼 | 歷史 |
| COLLCollegium Pharmaceutical, Inc | COM | 350,200 | $782.7 萬 | 0.3% | −3,900−1.1% | 減碼 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 657,280 | $752.6 萬 | 0.3% | −401,220−37.9% | 減碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 6,011,100 | $715.3 萬 | 0.3% | −68,900−1.1% | 減碼 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 1,581,142 | $624.6 萬 | 0.3% | +117,108+8.0% | 加碼 | 歷史 |
| GRTSGritstone bio, Inc. | COM | 2,733,800 | $470.2 萬 | 0.2% | −31,700−1.1% | 減碼 | 歷史 |
| ATECAlphatec Holdings, Inc. | COM NEW | 309,400 | $401.3 萬 | 0.2% | −83,600−21.3% | 減碼 | 歷史 |
| NSTGNS Wind Down Co., Inc. | COM | 2,299,100 | $395.4 萬 | 0.2% | −401,300−14.9% | 減碼 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 285,334 | $378.4 萬 | 0.2% | −593,266−67.5% | 減碼 | 歷史 |
| CMPXCompass Therapeutics, Inc. | COM | 1,599,600 | $315.1 萬 | 0.1% | −20,600−1.3% | 減碼 | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 1,159,900 | $301.6 萬 | 0.1% | −14,200−1.2% | 減碼 | 歷史 |
| SCYXScynexis Inc | COM NEW | 1,319,444 | $300.8 萬 | 0.1% | −419,290−24.1% | 減碼 | 歷史 |
| HYPRHyperfine, Inc. | COM CL A | 1,188,178 | $243.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 1,098,500 | $219.7 萬 | 0.1% | −12,400−1.1% | 減碼 | 歷史 |
| CMAXCareMax, Inc. | COM CL A | 636,000 | $134.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 89,543 | $8,954 | <0.1% | −1,017−1.1% | 減碼 | – |
2023 年第 2 季之後清倉（23 檔）
2023 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 2 季股數 | 2023 年第 2 季市值 | 2023 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| GEHCGE HealthCare Technologies Inc. | Stock | 1,045,400 | $8,493 萬 | 3.0% | 歷史 |
| ABBVAbbVie Inc. | Stock | 518,400 | $6,984 萬 | 2.4% | 歷史 |
| BIOBio-Rad Laboratories, Inc. | CL A | 152,600 | $5,785 萬 | 2.0% | 歷史 |
| CORCencora, Inc. | Stock | 300,000 | $5,773 萬 | 2.0% | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 468,700 | $4,270 萬 | 1.5% | 歷史 |
| PFEPfizer Inc | Stock | 1,117,467 | $4,099 萬 | 1.4% | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 1,425,000 | $3,496 萬 | 1.2% | 歷史 |
| BAXBaxter International Inc | Stock | 604,700 | $2,755 萬 | 1.0% | 歷史 |
| EDITEditas Medicine, Inc. | COM | 3,000,000 | $2,469 萬 | 0.9% | 歷史 |
| AXNXAxonics, Inc. | COM | 379,700 | $1,916 萬 | 0.7% | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 916,600 | $1,661 萬 | 0.6% | 歷史 |
| SLRNACELYRIN, Inc. | COM | 750,000 | $1,568 萬 | 0.5% | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 1,671,800 | $1,515 萬 | 0.5% | 歷史 |
| TSVT2seventy bio, Inc. | COMMON STOCK | 1,342,000 | $1,358 萬 | 0.5% | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 766,700 | $1,307 萬 | 0.5% | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 3,790,000 | $1,247 萬 | 0.4% | 歷史 |
| NARIInari Medical, Inc. | Stock | 175,000 | $1,017 萬 | 0.4% | 歷史 |
| ETNB89bio, Inc. | COM | 526,376 | $997.5 萬 | 0.3% | 歷史 |
| DNLIDenali Therapeutics Inc. | COM | 282,752 | $834.4 萬 | 0.3% | 歷史 |
| SLPSimulations Plus, Inc. | COM | 45,900 | $198.9 萬 | 0.1% | 歷史 |
| BHCBausch Health Companies Inc. | Stock | 215,100 | $172.1 萬 | 0.1% | 歷史 |
| Exscientia PLC30223G102 | ADS | 127,600 | $75.5 萬 | <0.1% | – |
| AIPArteris, Inc. | COM | 75,500 | $51.5 萬 | <0.1% | 歷史 |